Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-02

Clinical Trial Update: Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia [Phase 3]

View source ↗

Summary

Phase 3 trial results for Desmopressin Melt in nocturia, reporting efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desmopressin Melt (desmopressin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Nocturia | Phase 3 | Status: COMPLETED | Results posted: 2015-11-02